Search｜Photos & Images & Videos｜KYODO NEWS IMAGES INC

People Receive Food Aid In Jabalia Camp - Gaza

People wait to receive food relief at Jabalia refugee camp in the northern Gaza Strip, on August 21, 2024. Water, food and fuel supplies in Gaza are critically low, while diseases like Hepatitis A continue to spread across the strip, according to the UN Human Rights Office. Photo by Abdul Rahman Salama/Xinhua/ABACAPRESS.COM

E

People Receive Food Aid In Jabalia Camp - Gaza

A man receives food relief at Jabalia refugee camp in the northern Gaza Strip, on August 21, 2024. Water, food and fuel supplies in Gaza are critically low, while diseases like Hepatitis A continue to spread across the strip, according to the UN Human Rights Office. Photo by Abdul Rahman Salama/Xinhua/ABACAPRESS.COM

E

People Receive Food Aid In Jabalia Camp - Gaza

People wait to receive food relief at Jabalia refugee camp in the northern Gaza Strip, on August 21, 2024. Water, food and fuel supplies in Gaza are critically low, while diseases like Hepatitis A continue to spread across the strip, according to the UN Human Rights Office. Photo by Abdul Rahman Salama/Xinhua/ABACAPRESS.COM

E

People Receive Food Aid In Jabalia Camp - Gaza

People wait to receive food relief at Jabalia refugee camp in the northern Gaza Strip, on August 21, 2024. Water, food and fuel supplies in Gaza are critically low, while diseases like Hepatitis A continue to spread across the strip, according to the UN Human Rights Office. Photo by Abdul Rahman Salama/Xinhua/ABACAPRESS.COM

E

People Receive Food Aid In Jabalia Camp - Gaza

People wait to receive food relief at Jabalia refugee camp in the northern Gaza Strip, on August 21, 2024. Water, food and fuel supplies in Gaza are critically low, while diseases like Hepatitis A continue to spread across the strip, according to the UN Human Rights Office. Photo by Abdul Rahman Salama/Xinhua/ABACAPRESS.COM

E

People Receive Food Aid In Jabalia Camp - Gaza

A boy receives food relief at Jabalia refugee camp in the northern Gaza Strip, on August 21, 2024. Water, food and fuel supplies in Gaza are critically low, while diseases like Hepatitis A continue to spread across the strip, according to the UN Human Rights Office. Photo by Abdul Rahman Salama/Xinhua/ABACAPRESS.COM

E

People Receive Food Aid In Jabalia Camp - Gaza

People receive food relief at Jabalia refugee camp in the northern Gaza Strip, on August 21, 2024. Water, food and fuel supplies in Gaza are critically low, while diseases like Hepatitis A continue to spread across the strip, according to the UN Human Rights Office. Photo by Abdul Rahman Salama/Xinhua/ABACAPRESS.COM

E

People Receive Food Aid In Jabalia Camp - Gaza

A boy receives food relief at Jabalia refugee camp in the northern Gaza Strip, on August 21, 2024. Water, food and fuel supplies in Gaza are critically low, while diseases like Hepatitis A continue to spread across the strip, according to the UN Human Rights Office. Photo by Abdul Rahman Salama/Xinhua/ABACAPRESS.COM

E

EU health watchdog urges countries to boost fight against hepatitis

STORY: EU health watchdog urges countries to boost fight against hepatitis SHOOTING TIME: April 25, 2024 DATELINE: April 26, 2024 LENGTH: 00:00:57 LOCATION: Stockholm CATEGORY: HEALTH SHOTLIST: 1. various of European Center for Disease Prevention and Control (ECDC) 2. various of fact sheet of ECDC publication (credit: ECDC) 3. various of Stockholm street view STORYLINE: The European Union's (EU) health watchdog on Thursday urged its member states to boost testing for hepatitis B and C, which infected approximately 5.4 million people in Europe chronically. This could help prevent complications such as cirrhosis and liver cancer, the European Center for Disease Prevention and Control (ECDC) said. According to the center's latest estimate, around 3.6 million people in 30 countries in the EU/European Economic Area (EEA) are chronically infected with hepatitis B. A further 1.8 million people are estimated to have chronic hepatitis C. The prevalence of the disease varies considerably across countries and

E

Scientific And Technological Achievements Transformation in Hangzhou

HANGZHOU, CHINA - APRIL 8, 2024 - A recombinant hepatitis B vaccine is seen at Xihu District Science and Technology Transformation (Puhua) Center in Hangzhou city, Zhejiang province, China, April 8, 2024.

E

Türkiye to start domestic production of Hepatitis A vaccine: president

STORY: Türkiye to start domestic production of Hepatitis A vaccine: president SHOOTING TIME:Oct. 31, 2023 DATELINE: Nov. 1, 2023 LENGTH: 00:01:23 LOCATION: Ankara CATEGORY: HEALTH SHOTLIST: 1. various of the inauguration ceremony of the KeyVac Vaccine Production Center in Ankara 2. various of Erdogan visiting the vaccine production center STORYLINE: Hepatitis A vaccine, of which Türkiye gets mostly supplies from abroad, will be produced domestically, Turkish President Recep Tayyip Erdogan said Tuesday. Erdogan made the remarks at the inauguration ceremony of the KeyVac Vaccine Production Center in the Turkish capital of Ankara, a joint venture of Türkiye's Alagoz Holding and China's Sinovac Biotech, with a total factory area of 29,500 square meters. Türkiye will be the fourth country to produce this vaccine at the highest standard, Erdogan said. "Our dependence on foreign supplies will decrease. We will also have advanced and trained human resources," he added. Xinhua News Agency correspondents reporti

E

TÜRKIYE-ANKARA-HEPATITIS A VACCINE-JOINT VENTURE-INAUGURATION

(231031) -- ANKARA, Oct. 31, 2023 (Xinhua) -- Turkish President Recep Tayyip Erdogan (Rear) speaks at the inauguration ceremony of the KeyVac Vaccine Production Center in Ankara, Türkiye, on Oct. 31, 2023. Hepatitis A vaccine, of which Türkiye gets mostly supplies from abroad, will be produced domestically, Erdogan said Tuesday. Erdogan made the remarks at the inauguration ceremony of the KeyVac Vaccine Production Center in Ankara, a joint venture of Türkiye's Alagoz Holding and China's Sinovac Biotech, with a total factory area of 29,500 square meters. (Xinhua/Li Zhenbei)

E

TÜRKIYE-ANKARA-HEPATITIS A VACCINE-JOINT VENTURE-INAUGURATION

(231031) -- ANKARA, Oct. 31, 2023 (Xinhua) -- Turkish President Recep Tayyip Erdogan (C) visits the KeyVac Vaccine Production Center in Ankara, Türkiye, on Oct. 31, 2023. Hepatitis A vaccine, of which Türkiye gets mostly supplies from abroad, will be produced domestically, Erdogan said Tuesday. Erdogan made the remarks at the inauguration ceremony of the KeyVac Vaccine Production Center in Ankara, a joint venture of Türkiye's Alagoz Holding and China's Sinovac Biotech, with a total factory area of 29,500 square meters. (Xinhua/Li Zhenbei)

E

TÜRKIYE-ANKARA-HEPATITIS A VACCINE-JOINT VENTURE-INAUGURATION

(231031) -- ANKARA, Oct. 31, 2023 (Xinhua) -- Turkish President Recep Tayyip Erdogan speaks at the inauguration ceremony of the KeyVac Vaccine Production Center in Ankara, Türkiye, on Oct. 31, 2023. Hepatitis A vaccine, of which Türkiye gets mostly supplies from abroad, will be produced domestically, Erdogan said Tuesday. Erdogan made the remarks at the inauguration ceremony of the KeyVac Vaccine Production Center in Ankara, a joint venture of Türkiye's Alagoz Holding and China's Sinovac Biotech, with a total factory area of 29,500 square meters. (Xinhua/Li Zhenbei)

E

TÜRKIYE-ANKARA-HEPATITIS A VACCINE-JOINT VENTURE-INAUGURATION

(231031) -- ANKARA, Oct. 31, 2023 (Xinhua) -- Turkish President Recep Tayyip Erdogan (4th L) attends a ribbon cutting at the inauguration ceremony of the KeyVac Vaccine Production Center in Ankara, Türkiye, on Oct. 31, 2023. Hepatitis A vaccine, of which Türkiye gets mostly supplies from abroad, will be produced domestically, Erdogan said Tuesday. Erdogan made the remarks at the inauguration ceremony of the KeyVac Vaccine Production Center in Ankara, a joint venture of Türkiye's Alagoz Holding and China's Sinovac Biotech, with a total factory area of 29,500 square meters. (Xinhua/Li Zhenbei)

E

First settlement reached in hepatitis damages suits against state

FUKUOKA, Japan - A total of 29 hepatitis C sufferers suing the state and drugmakers for damages settled suits with the state in Osaka and Fukuoka on Feb. 4, the first such settlement among a series of similar lawsuits filed by about 240 people nationwide since 2002. Photo shows plaintiffs smiling during a news conference the same day after the settlement of their suit at the Fukuoka High Court.

E

State ruled not responsible for hepatitis C

SENDAI, Japan - Chiyoko Komatsu, whose husband Tadao died after being administered tainted blood products, is moved to tears during a press conference in Sendai on Sept. 7. The Sendai District Court found the government not responsible for the case involving Komatsu and five other people.

E

Hepatitis group chief

TOKYO, Japan - Charles Gore, president of the World Hepatitis Alliance, speaks at a press conference in Tokyo on July 26, 2012, ahead of World Hepatitis Day on July 28.

E

PM Kan apologizes over hepatitis B infections

TOKYO, Japan - Japanese Prime Minister Naoto Kan (R) apologizes to Mieko Taniguchi, the leader of plaintiffs in damages suits brought against the state over contractions of hepatitis B, at the prime minister's office in Tokyo on June 28, 2011, after the Japanese government and the plaintiffs signed a basic agreement. The government will pay damages to people infected with the hepatitis B virus through reused needles in group vaccinations between 1948 and 1988.

E

Basic agreement on hepatitis B infections

TOKYO, Japan - Japanese health minister Ritsuo Hosokawa (R) and Mieko Taniguchi, the leader of plaintiffs in damages suits brought against the state over contractions of hepatitis B, shake hands at the health ministry in Tokyo on June 28, 2011, after the Japanese government and the plaintiffs signed a basic agreement. The government will pay damages to people infected with the hepatitis B virus through reused needles in group vaccinations between 1948 and 1988.

E

Hepatitis B sufferers to accept court proposal

TOKYO, Japan - Mieko Taniguchi, the leader of plaintiffs suffering from hepatitis B, speaks at a meeting in Tokyo on Jan. 22, 2011. The plaintiffs decided the same day to accept a court-proposed settlement plan for lawsuits against the government on condition that the state offers an apology and blanket compensation.

E

Hepatitis B sufferers, gov't seek settlement of lawsuits

SAPPORO, Japan - Hepatitis B sufferers enter the Sapporo District Court in Hokkaido on May 14, 2010, for a hearing of a lawsuit demanding the state compensate them for failing to take steps to avert the risks posed by shared needles during mass vaccinations. The government formally announced that day it will enter into talks to settle a string of such lawsuits.

E

Hepatitis B sufferers, gov't seek settlement of lawsuits

SAPPORO, Japan - Hepatitis B sufferers enter the Sapporo District Court in Hokkaido on May 14, 2010, for a hearing of a lawsuit demanding the state compensate them for failing to take steps to avert the risks posed by shared needles during mass vaccinations. The government formally announced that day it will enter into talks to settle a string of such lawsuits.

E

Court urges compromise settlement in hepatitis damages suit

SAPPORO, Japan - A lawyer holds up a banner in front of the Sapporo District Court in Sapporo on March 12, 2010, after the court urged plaintiffs and the government to reach a compromise settlement in a damages suit involving hepatitis B virus infection caused by the reuse of hypodermic needles in group vaccinations. Among 10 similar suits filed with nine other district courts across Japan, the Sapporo court was the first to urge parties to reach a compromise settlement.

E

Law to offer comprehensive relief to hepatitis patients enacted

TOKYO, Japan - A plenary session of the House of Councillors approves a law to offer financial support and other comprehensive relief to hepatitis patients on Nov. 30, 2009, although the members of the opposition Liberal Democratic Party abstained from voting.

E

Law to offer comprehensive relief to hepatitis patients enacted

TOKYO, Japan - Eriko Fukuda (L), a House of Representatives lawmaker of the ruling Democratic Party of Japan, observes a plenary session of the House of Councillors on Nov. 30, 2009, as the upper house approves a law to offer financial support and other comprehensive relief to hepatitis patients. Fukuda led a group of hepatitis C patients in a lawsuit against the government and won her Diet seat in the August election.

E

Lower house passes hepatitis bill, enactment seen certain

TOKYO, Japan - Michiko Yamaguchi, the representative of a national group of hepatitis patients who have filed a lawsuit against the government and drug makers, speaks at a news conference in Tokyo on Nov. 26 after a plenary session of the House of Representatives passed a measure to support hepatitis patients.

E

6-yr court battle over hepatitis C completed

TOKYO, Japan - Michiko Yamaguchi, representative of the plaintiffs group, signs an agreement with Nihon Pharmaceutical Co. at the drug firm's headquarters in Tokyo's Chiyoda Ward on Dec. 14 to end a series of damages suits over tainted blood products that infected the patients with a hepatitis virus.

E

6-yr court battle over hepatitis C completed

TOKYO, Japan - Tsutomu Miura (R), president of Nihon Pharmaceutical Co., bows in apology to a group of hepatitis patients, including plaintiffs' group representative Michiko Yamaguchi (L), at the drug firm's headquarters in Tokyo's Chiyoda Ward on Dec. 14 after they signed an agreement to end a series of damages suits over tainted blood products that infected the patients with a hepatitis virus.

E

6-yr court battle over hepatitis C completed

TOKYO, Japan - Tsutomu Miura, president of Nihon Pharmaceutical Co., signs an agreement with a group of hepatitis patients at the firm's headquarters in Tokyo's Chiyoda Ward on Dec. 14 to end a series of damages suits over the drug firm's tainted blood products that infected the patients with a hepatitis virus.

E

21 more plaintiffs reach settlement in hepatitis-C damages suit

TOKYO, Japan - Some of the 21 plaintiffs from 11 prefectures suing the state and drug makers for hepatitis-C damages respond to questions from reporters in Tokyo after they settled their suit with the state in Tokyo on Feb. 29.

E

Gov't, hepatitis C patients sign accord to end legal battle

TOKYO, Japan - Health, Labor and Welfare Minister Yoichi Masuzoe (L) bows before the representatives of the plaintiffs in hepatitis C damages lawsuits against the state and drugmakers, at the Health, Labor and Welfare Ministry in Tokyo on Jan. 15 after the two sides signed a basic accord to end the protracted legal battle. The agreement is based on a law enacted last week offering blanket relief to those who contracted the liver illness through contaminated blood products such as fibrinogen which were administered to stop bleeding.

E

Gov't, hepatitis C patients sign accord to end legal battle

TOKYO, Japan - Health, Labor and Welfare Minister Yoichi Masuzoe (R) shakes hands with Michiko Yamaguchi, leader of the plaintiffs in hepatitis C damages lawsuits against the state and drugmakers, at the Health, Labor and Welfare Ministry in Tokyo on Jan. 15 after the two sides signed a basic accord to end the protracted legal battle. The agreement is based on a law enacted last week offering blanket relief to those who contracted the liver illness through contaminated blood products such as fibrinogen which were administered to stop bleeding.

E

Relief law enacted for hepatitis C sufferers

TOKYO, Japan - Plaintiffs in a hepatitis C damages case show their emotions Jan. 11 after the House of Councillors at a plenary session unanimously passed into law a bill that will offer blanket relief to people with hepatitis C caused by tainted blood products.

E

Relief law enacted for hepatitis C sufferers

TOKYO, Japan - Japan's House of Councillors at its plenary session Jan. 11 unanimously passed into law a bill that will offer blanket relief to people with hepatitis C caused by tainted blood products. Plaintiffs (top, R) in the case observe the plenary session.

E

Lower house passes hepatitis relief bill

TOKYO, Japan - Plaintiffs in a hepatitis C case bow in a gesture of gratitude in the gallery of the Japanese House of Representatives in Tokyo on Jan. 8. The lower house passed a bill the same day to offer blanket relief to people with hepatitis C caused by tainted blood products, paving the way for its passage through the opposition-controlled House of Councillors for enactment into law possibly later in the week.

E

Lower house passes hepatitis relief bill

TOKYO, Japan - Health, Labor and Welfare Minister Yoichi Masuzoe bows in apology at a plenary session of the House of Representatives on Jan. 8 after the lower house unanimously approved a bill to offer blanket relief to people with hepatitis C caused by tainted blood products.

E

Lower house passes hepatitis relief bill

TOKYO, Japan - A plenary session of the House of Representatives unanimously approved a bill on Jan. 8 to offer blanket relief to people with hepatitis C caused by tainted blood products, paving the way for enactment into law possibly later in the week in the opposition-controlled House of Councillors.

E

Relief bill for hepatitis C sufferers submitted to Diet

TOKYO, Japan - Michiko Yamaguchi (R), a representative of the country's hepatitis C plaintiffs groups, speaks during a press conference in Tokyo on Jan. 7. The ruling coalition of the Liberal Democratic Party and the New Komeito party submitted a bill to the Diet earlier in the day to offer blanket relief to people with hepatitis C contracted through tainted blood products.

E

Talks focus on gov't responsibility for hepatitis C outbreak

TOKYO, Japan - Former Health, Labor and Welfare Minister Jiro Kawasaki, leader of a ruling coalition project team, talks to reporters in Tokyo on Dec. 27 after a meeting with lawyers representing people infected with hepatitis C via tainted blood products aimed at working out a bill to offer them blanket government relief. The talks focused on how the bill will mention the state's responsibility for the suffering of the hepatitis patients, participants said.

E

Fukuda offers apologies to plaintiffs in hepatitis C case

TOKYO, Japan - Two combined photos shows Prime Minister Yasuo Fukuda (R) offering apologies to representatives (L) of the plaintiffs, who filed damages lawsuits against the state and drug makers over their contraction of hepatitis C through tainted blood products.

E

Bill may cite gov't responsibility for hepatitis C infections

TOKYO, Japan - Prime Minister Yasuo Fukuda speaks to reporters at the prime minister's office in Tokyo on Dec. 24, indicating that special legislation to aid hepatitis C patients who were infected by tainted blood products would mention the state's responsibility for the infections.

E

Ruling camp to craft bill to aid all hepatitis C sufferers

TOKYO, Japan - Prime Minister Yasuo Fukuda speaks to journalists at his office on Dec. 23. He said the ruling coalition parties will craft legislation to aid all hepatitis C sufferers who contracted the disease through tainted blood products.

E

Ruling camp to craft bill to aid all hepatitis C sufferers: Fukuda

TOKYO, Japan - Prime Minister Yasuo Fukuda speaks to journalists at his office on Dec. 23. He said that the ruling coalition parties will craft legislation to aid all hepatitis C sufferers who contracted the disease through tainted blood products. ''As a result of consultations with the Liberal Democratic Party, we have decided to devise a lawmaker-initiated bill to aid all the sufferers uniformly,'' Fukuda said.

E

Gov't rejects uniform compensation for all hepatitis C sufferers

TOKYO, Japan - Health, Labor and Welfare Minister Yoichi Masuzoe bites his lip during a press conference on Dec. 20 after his ministry rejected a proposal from hepatitis C sufferers that the government pay compensation uniformly to all people who contracted the disease through tainted blood products to settle a long-standing damages lawsuit out of court.

E

Health minister apologizes to victims for hepatitis C infections

TOKYO, Japan - Health, Labor and Welfare Minister Yoichi Masuzoe (C) meets with a group of people who were infected with hepatitis C through a tainted blood product, in Tokyo on Dec. 4. Masuzoe offered an apology to them for the first time for the government's inaction over the infections.

E

Court urges gov't to settle suits with hepatitis C patients

OSAKA, Japan - Tomoko Kuwata, one of 13 plaintiffs who filed a lawsuit against the government and drug makers, wipes away tears in Osaka on Nov. 7 after the Osaka High Court called on the government and the drug makers to reach a negotiated settlement with the plaintiffs, who were infected with hepatitis-C through tainted blood products.

E

Court urges gov't to settle suits with hepatitis C patients

TOKYO, Japan - Health, Labor and Welfare Minister Yoichi Masuzoe speaks to reporters at the parliament building in Tokyo on Nov. 7 after the Osaka High Court called on the government and drug makers to reach a negotiated settlement of damages lawsuits filed by people infected with hepatitis-C through tainted blood products.

E

Court urges gov't to settle suits with hepatitis C patients

OSAKA, Japan - Plaintiffs seeking damages over hepatitis-C diseases enter the Osaka High Court to attend a court session on Nov. 7. The court called on the government and drug makers for a negotiated settlement of damages lawsuits filed by people who were infected with hepatitis-C through tainted blood products.

E

Ministry finds initials, names of 118 hepatitis C patients

TOKYO, Japan - Health, Labor and Welfare Minister Yoichi Masuzoe (R) meets with Natsuki Hayama (C), president of Mitsubishi Tanabe Pharma Corp., and Takeshi Komine (L), the company's vice president, at the health ministry on Oct. 22, after the ministry said it has found documents with the names or initials of 118 out of 418 people who developed hepatitis C through the administration of a tainted blood product, reversing its earlier claim that it had no data to confirm any of their identities. The product was manufactured by now-defunct Green Cross Corp., which was taken over by Mitsubishi Tanabe Pharma.